Dosing and Administration
The convenience of oral dosing across 6 indications
XARELTO® offers convenient oral dosing and administration with no routine coagulation monitoring.1-7 XARELTO® requires no dose adjustments based on age, body weight, or gender. See guidelines for switching patients to and from XARELTO® and bleed management.
Renal dosing considerations
- Nonvalvular AF: Periodically assess renal function as clinically indicated (ie, more frequently in situations in which renal function may decline) and adjust therapy accordingly. Consider dose adjustment or discontinuation of XARELTO® in patients who develop acute renal failure while on XARELTO®
- All other indications: Avoid using XARELTO® in patients with CrCl <30 mL/min
Please see full Prescribing Information for additional dosing considerations.